The DOI matches its Crossref record; 99 of the 99 references it cites were found in a registry or an index.
Cisplatin resistance and opportunities for precision medicine
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Platinum Compounds: a New Class of Potent Antitumour Agents
ROSENBERG, B., VANCAMP, L., TROSKO, J. E., & MANSOUR, V. H. (1969) · Nature · doi:10.1038/222385a0 · Cited by 3,972
Inhibition of Cell Division in Escherichia coli by Electrolysis Products from a Platinum Electrode
ROSENBERG, B., VAN CAMP, L., & KRIGAS, T. (1965) · Nature · doi:10.1038/205698a0 · Cited by 3,049
Molecular mechanisms of resistance and toxicity associated with platinating agents
Rabik, C. A., & Dolan, M. E. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.09.006 · Cited by 1,564
Godwin, A. K., Meister, A., O'Dwyer, P. J., Huang, C. S., Hamilton, T. C., & Anderson, M. E. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.7.3070 · Cited by 925
Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882
Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin.
Markman, M., Rothman, R., Hakes, T., Reichman, B., Hoskins, W., Rubin, S., Jones, W., Almadrones, L., & Lewis, J. L. (1991) · Journal of Clinical Oncology · doi:10.1200/jco.1991.9.3.389 · Cited by 839
Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells.
Cole, S. P. C., Sparks, K. E., Fraser, K., Loe, D. W., Grant, C. E., Wilson, G. M., & Deeley, R. G. (1994) · PubMed · Cited by 770
Watson, M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.2.275 · Cited by 668
Lord, R. V., Brabender, J., Gandara, D. R., Alberola, V., Camps, C., Dómine, M., Cardenal, F., Sánchez, J. M., Gumerlock, P. H., Tarón, M., et al. (2002) · PubMed · Cited by 668
Overexpression of Metallothionein Confers Resistance to Anticancer Drugs
Kelley, S. L., Basu, A., Teicher, B. A., Hacker, M. P., Hamer, D. H., & Lazo, J. S. (1988) · Science · doi:10.1126/science.3175622 · Cited by 601
Cellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
Metzger, R., Leichman, C. G., Danenberg, K. D., Danenberg, P. V., Lenz, H. J., Hayashi, K., Groshen, S., Salonga, D., Cohen, H., Laine, L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.309 · Cited by 505
Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients.
Spitz, M. R., Wu, X., Wang, Y., Wang, L.-E., Shete, S. S., Amos, C. I., Guo, Z., Lei, L., Mohrenweiser, H. W., & Wei, Q. (2001) · PubMed · Cited by 489
The Role of Cellular Accumulation in Determining Sensitivity to Platinum-Based Chemotherapy
Hall, M. D., Okabe, M., Shen, D.-W., Liang, X.-J., & Gottesman, M. M. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.080907.180426 · Cited by 474
Taniguchi, K., WADA, M., Kohno, K., Nakamura, T., Kawabe, T., Kawakami, M., Kagotani, K., Okumura, K., Akiyama, S.-I., & Kuwano, M. (1996) · PubMed · Cited by 470
Cancer chemotherapy and biotherapy: Principles and practice
Ellis, L. E. (1997) · Surgical Oncology · doi:10.1016/s0960-7404(97)00005-4 · Cited by 418
Samimi, G., Safaei, R., Katano, K., Holzer, A. K., Rochdi, M., Tomioka, M., Goodman, M., & Howell, S. B. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0137 · Cited by 358
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z., Terada, K., Furukawa, T., Yang, X., Gao, H., Miura, N., Sugiyama, T., et al. (2000) · PubMed · Cited by 328
Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II)
Eastman, A., & Schulte, N. (1988) · Biochemistry · doi:10.1021/bi00413a022 · Cited by 312
ERCC1 and ERCC2 Expression in Malignant Tissues From Ovarian Cancer Patients
Dabholkar, M., Bostick-Bruton, F., Weber, C., Bohr, V. A., Egwuagu, C., & Reed, E. (1992) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/84.19.1512 · Cited by 305
Katano, K., Kondo, A., Safaei, R., Holzer, A. K., Samimi, G., Mishima, M., Kuo, Y., Rochdi, M., & Howell, S. B. (2002) · PubMed · Cited by 291
Zhou, W., Gurubhagavatula, S., Liu, G., Park, S., Neuberg, D. S., Wain, J. C., Lynch, T. J., Su, L., & Christiani, D. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-0247 · Cited by 291
Enhancing Tumor-Specific Uptake of the Anticancer Drug Cisplatin with a Copper Chelator
Ishida, S., McCormick, F., Smith-McCune, K., & Hanahan, D. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.04.011 · Cited by 288
Increased nucleotide excision repair in cisplatin-resistant ovarian cancer cells
Ferry, K. V., Hamilton, T. C., & Johnson, S. W. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00441-x · Cited by 275
(1992) · Lung Cancer · doi:10.1016/0169-5002(92)90185-m · Cited by 237
The Copper Transporter CTR1 Regulates Cisplatin Uptake in Saccharomyces cerevisiae
Lin, X., Okuda, T., Holzer, A., & Howell, S. B. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.5.1154 · Cited by 232
Drug transporters of platinum-based anticancer agents and their clinical significance
Burger, H., Loos, W. J., Eechoute, K., Verweij, J., Mathijssen, R. H. J., & Wiemer, E. A. C. (2011) · Drug Resistance Updates · doi:10.1016/j.drup.2010.12.002 · Cited by 230
Richon, V. M., Schulte, N. A., & Eastman, A. R. (1987) · PubMed · Cited by 229
Viguier, J., Boige, V., Miquel, C., Pocard, M., Giraudeau, B., Sabourin, J.-C., Ducreux, M., Sarasin, A., & Praz, F. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2216 · Cited by 226
van den Berghe, P. V. E., Folmer, D. E., Malingré, H. E. M., van Beurden, E., Klomp, A. E. M., van de Sluis, B., Merkx, M., Berger, R., & Klomp, L. W. J. (2007) · Biochemical Journal · doi:10.1042/bj20070705 · Cited by 217
Ishikawa, T., Wright, C. D., & Ishizuka, H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)62016-8 · Cited by 206
Yu, J. J., Lee, K. B., Mu, C., Li, Q., Abernathy, T. V., Bostick-Bruton, F., & Reed, E. (2000) · International Journal of Oncology · doi:10.3892/ijo.16.3.555 · Cited by 200
Cancer Chemotherapy and Biotherapy : Principles and Practice
Burney, I. (2011) · Sultan Qaboos University Medical Journal · doi:10.18295/2075-0528.1308 · Cited by 185
van der Zee, A. G., Hollema, H., Suurmeijer, A. J., Krans, M., Sluiter, W. J., Willemse, P. H., Aalders, J. G., & de Vries, E. G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.70 · Cited by 184
Hinoshita, E., Uchiumi, T., Taguchi, K., Kinukawa, N., Tsuneyoshi, M., Maehara, Y., Sugimachi, K., & Kuwano, M. (2000) · PubMed · Cited by 179
Association of an ERCC1 polymorphism with adult-onset glioma.
Chen, P., Wiencke, J. K., Aldape, K., Kesler-Diaz, A., Miike, R., Kelsey, K. T., Lee, M., Liu, J., & Wrensch, M. (2000) · PubMed · Cited by 177
Relevance of drug uptake and efflux for cisplatin sensitivity of tumor cells
Zisowsky, J., Koegel, S., Leyers, S., Devarakonda, K. R., Kassack, M. U., Osmak, M., & Jaehde, U. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.10.003 · Cited by 174
Weaver, D. A., Crawford, E. L., Warner, K. A., Elkhairi, F., Khuder, S., & Willey, J. C. (2005) · Molecular Cancer · doi:10.1186/1476-4598-4-18 · Cited by 171
Interaction of Cisplatin with the Human Organic Cation Transporter 2
Filipski, K. K., Loos, W. J., Verweij, J., & Sparreboom, A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4793 · Cited by 169
Li, Q., Yu, J., Mu, C., Yunmbam, M. K., Slavsky, D., Cross, C. L., Bostick-Bruton, F., & Reed, E. (2000) · PubMed · Cited by 161
Blair, B. G., Larson, C., Safaei, R., & Howell, S. B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0311 · Cited by 154
Nakayama, K., Kanzaki, A., Ogawa, K., Miyazaki, K., Neamati, N., & Takebayashi, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10608 · Cited by 145
Yamasaki, M., Makino, T., Masuzawa, T., Kurokawa, Y., Miyata, H., Takiguchi, S., Nakajima, K., Fujiwara, Y., Matsuura, N., Mori, M., et al. (2011) · British Journal of Cancer · doi:10.1038/sj.bjc.6606071 · Cited by 140
Samimi, G., Varki, N. M., Wilczynski, S. P., Safaei, R., Alberts, D. S., & Howell, S. B. (2003) · PubMed · Cited by 139
Burger, H., Zoumaro-Djayoon, A. D., Boersma, A., Helleman, J., Berns, E., Mathijssen, R. H. J., Loos, W., & Wiemer, E. A. C. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00569.x · Cited by 122
The many highways for intracellular trafficking of metals
Luk, E., Jensen, L. T., & Culotta, V. (2003) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s00775-003-0482-3 · Cited by 120
Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy
Perego, P., & Robert, J. (2015) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-015-2901-x · Cited by 117
Nakayama, K., Kanzaki, A., Terada, K., Mutoh, M., Ogawa, K., Sugiyama, T., Takenoshita, S., Itoh, K., Yaegashi, N., Miyazaki, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0454 · Cited by 114
Wakai (2010) · Oncology Reports · doi:10.3892/or_00000721 · Cited by 108
The mammalian copper transporters CTR1 and CTR2 and their roles in development and disease
Wee, N. K. Y., Weinstein, D. C., Fraser, S. T., & Assinder, S. J. (2013) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2013.01.018 · Cited by 107
Byun, S., Kim, S. W., Choi, H., Lee, C., & Lee, E. (2005) · British Journal of Urology · doi:10.1111/j.1464-410x.2005.05472.x · Cited by 105
MRP2 and GSTP1 polymorphisms and chemotherapy response in advanced non-small cell lung cancer
Sun, N., Sun, X., Chen, B., Cheng, H., Feng, J., Cheng, L., & Lu, Z. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1046-1 · Cited by 100
Surowiak, P., Materna, V., Kaplenko, I., Spaczyński, M., Dietel, M., Lage, H., & Zabel, M. (2005) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-005-1228-0 · Cited by 98
Chen, H. H. W., Yan, J., Chen, W.-C., Kuo, M. T., Lai, Y.-H., Lai, W. W., Liu, H., & Su, W. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.06.011 · Cited by 97
Smith, S., Su, D., de la Longrais, I. A. R., Schwartz, P. E., Puopolo, M., Rutherford, T., Mor, G., Yu, H., & Katsaros, D. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.11.8547 · Cited by 94
Metallothionein: A multifunctional protein from toxicity to cancer
Theocharis, S. E., Margeli, A. P., & Koutselinis, A. S. (2003) · The International Journal of Biological Markers · doi:10.5301/jbm.2008.196 · Cited by 92
Tissue Platinum Concentration and Tumor Response in Non–Small-Cell Lung Cancer
Kim, E. S., Lee, J. J., He, G., Chow, C.-W. B., Fujimoto, J., Kalhor, N., Swisher, S. G., Wistuba, I. I., Stewart, D. J., & Siddik, Z. H. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.40.8120 · Cited by 91
Copper transporter CTR1 expression and tissue platinum concentration in non-small cell lung cancer
Kim, E. S., Tang, X., Peterson, D. R., Kilari, D., Chow, C.-W. B., Fujimoto, J., Kalhor, N., Swisher, S. G., Stewart, D. J., Wistuba, I. I., et al. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.04.005 · Cited by 88
Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD.
Aloyz, R. S., Xu, Z., Bello, V., Bergeron, J., Han, F., Yan, Y., Malapetsa, A., Alaoui‐Jamali, M. A., Duncan, A. M. V., & Panasci, L. (2002) · PubMed · Cited by 88
Mechanistic Basis for Overcoming Platinum Resistance Using Copper Chelating Agents
Zheng, L., Long, Y., Tsai, W.-B., Fu, S., Kurzrock, R., Gagea-Iurascu, M., Zhang, F., Chen, H. H. W., Hennessy, B. T., Mills, G. B., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0580 · Cited by 88
Miyashita, H., Nitta, Y., Mori, S., Kanzaki, A., Nakayama, K., Terada, K., Sugiyama, T., Kawamura, H., Satō, A., MORIKAWA, H., et al. (2003) · Oral Oncology · doi:10.1016/s1368-8375(02)00038-6 · Cited by 83
Filipits, M., Haddad, V., Schmid, K., Huynh, A. T., Dunant, A., André, F., Brambilla, E. M., Stahel, R. A., Pignon, J., Soria, J., et al. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2446 · Cited by 82
ATP-binding cassette superfamily transporter gene expression in human primary ovarian carcinoma.
Ohishi, Y., Oda, Y., Uchiumi, T., Kobayashi, H., Hirakawa, T., Miyamoto, S., Kinukawa, N., Nakano, H., Kuwano, M., & Tsuneyoshi, M. (2002) · PubMed · Cited by 80
Predicting cisplatin and trabectedin drug sensitivity in ovarian and colon cancers
Stevens, E. V., Nishizuka, S., Antony, S., Reimers, M., Varma, S., Young, L., Munson, P. J., Weinstein, J. N., Kohn, E. C., & Pommier, Y. G. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0192 · Cited by 76
on behalf of Bio-FAST trial group, Tiseo, M., Bordi, P., Bortesi, B., Boni, L., Boni, C., Baldini, E., Grossi, F., Recchia, F., Zanelli, F., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.127 · Cited by 73
Hishikawa, Y., Abe, S., Kinugasa, S., Yoshimura, H., Monden, N., Igarashi, M., Tachibana, M., & Nagasue, N. (2009) · Oncology · doi:10.1159/000227714 · Cited by 70
Aida, T., Takebayashi, Y., Shimizu, T., Okamura, C., Higasimoto, M., Kanzaki, A., Nakayama, K., Terada, K., Sugiyama, T., Miyazaki, K., et al. (2005) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.12.042 · Cited by 68
Huang, J., Zhou, Y., Zhang, H., Qu, T., Mao, Y., Zhu, H., Quan, L., Xing, P., Wang, J., He, J., et al. (2012) · Medical Oncology · doi:10.1007/s12032-012-0343-4 · Cited by 68
Townsend, A. J., Tu, C., & Cowan, K. H. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)08863-7 · Cited by 66
Li, Z., Qing, Y., Guan, W., Li, M., Peng, Y., Shiheng, Z., Xiong, Y., & Wang, D. (2014) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-014-2562-1 · Cited by 66
Reed, E., Yu, J., Davies, A., Gannon, J., & Armentrout, S. L. (2003) · PubMed · Cited by 65
The relationship between cisplatin sensitivity and drug uptake into mammalian cells in vitro
Eichholtz-Wirth, H., & Hietel, B. (1986) · British Journal of Cancer · doi:10.1038/bjc.1986.168 · Cited by 61
Ludovini, V., Floriani, I., Pistola, L., Minotti, V., Meacci, M., Chiari, R., Garavaglia, D., Tofanetti, F. R., Flacco, A., Siggillino, A., et al. (2011) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182307e1f · Cited by 59
The Proteomic Analysis of Cisplatin Resistance in Breast Cancer Cells
Smith, L., Welham, K. J., Watson, M. B., Drew, P. J., Lind, M., & Cawkwell, L. (2007) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/096504007783438358 · Cited by 59
Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma
Ohbu, M., Ogawa, K., 今野, 宗., Kanzaki, A., Terada, K., Sugiyama, T., & Takebayashi, Y. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00462-7 · Cited by 58
Wheeler, H. E., Gamazon, E. R., Stark, A. L., O’Donnell, P. H., Gorsic, L. K., Huang, R. S., Cox, N. J., & Dolan, M. E. (2011) · The Pharmacogenomics Journal · doi:10.1038/tpj.2011.38 · Cited by 56
Han, B., Gao, G., Wu, W., Gao, Z., Zhao, X., Li, L., Qiao, R., Chen, H., Wei, Q., Wu, J., et al. (2010) · Lung Cancer · doi:10.1016/j.lungcan.2010.09.001 · Cited by 54
Goričar, K., Kovač, V., Jazbec, J., Zakotnik, B., Lamovec, J., & Dolžan, V. (2015) · Cancer Epidemiology · doi:10.1016/j.canep.2014.12.009 · Cited by 48
Kamikozuru, H., Kuramochi, H., Hayashi, K., Nakajima, G., & Yamamoto, M. (2008) · International Journal of Oncology · doi:10.3892/ijo.32.5.1091 · Cited by 47
Role of metallothionein in cisplatin sensitivity of germ-cell tumours
Meijer, C., Timmer, A., de Vries, E. G. E., Groten, J. P., Knol, A., Zwart, N., Dam, W., Sleijfer, D. T., & Mulder, N. H. (2000) · International Journal of Cancer · Cited by 47
Association of copper transporter expression with platinum resistance in epithelial ovarian cancer.
Yoshida, H., TERAMAE, M., Yamauchi, M., Fukuda, T., Yasui, T., Sumi, T., Honda, K.-I., & Ishiko, O. (2013) · PubMed · Cited by 42
Lee, S. H., Noh, K. B., Lee, J. S., Lee, E. J., Min, K. H., Hur, G. Y., Lee, S. H., Lee, S. Y., Kim, J. H., Lee, S. Y., et al. (2013) · Lung Cancer · doi:10.1016/j.lungcan.2013.03.002 · Cited by 42
Ikuta, K., Takemura, K., Sasaki, K., Kihara, M., Nishimura, M., Ueda, N., Naito, S., Lee, E., Shimizu, E., & Yamauchi, A. (2005) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.28.707 · Cited by 40
Kim, K. H., Kwon, H.-C., Oh, S. Y., Kim, S. H., Lee, S., Kwon, K. A., Jang, J. S., Kim, M. C., Kim, S.-J., & Kim, H. (2010) · Biomarkers · doi:10.3109/1354750x.2010.533284 · Cited by 39
Cisplatin-resistant bladder carcinoma cells: enhanced expression of metallothioneins
Siegsmund, M. J., Marx, C., Seemann, O., Schummer, B., Steidler, A., Toktomambetova, L., Köhrmann, K.-U., Rassweiler, J. J., & Alken, P. M. (1999) · Urological Research · doi:10.1007/s002400050103 · Cited by 39
The Association of Transporter Genes Polymorphisms and Lung Cancer Chemotherapy Response
Wang, Y., Yin, J., Li, X., Chen, J., Qian, C., Zheng, Y., Fu, Y., Chen, Z., Zhou, H., & Liu, Z. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091967 · Cited by 36
Cheng, J., Min-wen, H., Wang, Y., Sun, J., Chen, J., Wang, Y., & Tong, C. (2011) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-011-1090-1 · Cited by 33
Xie, K., He, H., Sun, A., Liu, X.-B., Sun, L. L., & Dong, X.-J. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.6.2591 · Cited by 33
Wang, C., Wu, H. T., Cheng, H. M., Yen, T.-J., Lu, I.-H., Chang, H. C., Jao, S., Shing, T. K. M., & Li, W. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201131n · Cited by 33
Watson, M. B., Lind, M., Smith, L., Drew, P. J., & Cawkwell, L. (2007) · Acta Oncologica · doi:10.1080/02841860601156157 · Cited by 31
Hwang, I. G., Jang, J.-S., Do, J. H., Kang, J. H., Lee, G. W., Oh, S. Y., Kwon, H.-C., Jun, H. J., Lim, H. Y., Lee, S., et al. (2011) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-011-1558-3 · Cited by 30
Ma, X., Huang, J.-W., Wei, D., Hongyu, Z., Zhang, J., Shi, C., & Liu, L. (2015) · Oral Oncology · doi:10.1016/j.oraloncology.2015.02.094 · Cited by 28
Yamashita, F., Azuma, K., Yoshida, T., Yamada, K., Kawahara, A., Hattori, S., Takeoka, H., Zaizen, Y., Kawayama, T., Kage, M., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071356 · Cited by 24
Hattinger, C. M., Michelacci, F., Sella, F., Magagnoli, G., Benini, S., Gambarotti, M., Palmerini, E., Picci, P., Serra, M., & Ferrari, S. (2015) · Histopathology · doi:10.1111/his.12653 · Cited by 24
Deng, J., Deng, J., Shi, D., Ouyang, X.-N., & Niu, P. (2015) · Clinical & Translational Oncology · doi:10.1007/s12094-015-1299-6 · Cited by 23
Ulker, M., Duman, B. B., Şahin, B., & Gümürdülü, D. (2015) · Współczesna Onkologia · doi:10.5114/wo.2015.52656 · Cited by 21
Ho, S.-P. (2011) · Oncology Reports · doi:10.3892/or.2011.1184 · Cited by 20
Zwenger, A. O., Grosman, G., Iturbe, J., Leone, J., Vallejo, C. T., Leone, J. P., Verdera, P. P., Perez, J. E., & Leone, B. A. (2015) · The International Journal of Biological Markers · doi:10.5301/jbm.5000161 · Cited by 13
Schneider, J. G., Farhadfar, N., Sivapiragasam, A., Geller, M. D., Islam, S., & Selbs, E. (2014) · The Oncologist · doi:10.1634/theoncologist.2013-0311 · Cited by 10
Cited by
The side effects of platinum-based chemotherapy drugs: a review for chemists
Oun, R., Moussa, Y. E., & Wheate, N. J. (2018) · Dalton Transactions · doi:10.1039/c8dt00838h · Cited by 1,737
Colorectal Carcinoma: A General Overview and Future Perspectives in Colorectal Cancer
Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E., & Rodriguez Yoldi, M. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18010197 · Cited by 1,525
Ferroptosis: A Novel Anti-tumor Action for Cisplatin
Guo, J., Xu, B., Han, Q., Zhou, H., Xia, Y., Gong, C., Dai, X., Li, Z., & Wu, G. (2018) · Cancer Research and Treatment · doi:10.4143/crt.2016.572 · Cited by 777
Ferroptosis, a novel pharmacological mechanism of anti-cancer drugs
Su, Y., Zhao, B., Zhou, L., Zhang, Z., Shen, Y., Lv, H., AlQudsy, L. H. H., & Shang, P. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.015 · Cited by 576
New Insights into Mechanisms of Cisplatin Resistance: From Tumor Cell to Microenvironment
Chen, S.-H., & Chang, J.-Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174136 · Cited by 428
Metadata
- Authors
- Amable, L.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2016-04
- Volume
- 106
- Pages
- 27-36
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W2274595380
- Cited by
- 589
- References
- 99
- FWCI
- 19.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.